1.      Daniels TE and Fox PC: Salivary and oral components of Sjogren's syndrome. Rheum Dis Cli North Am.1992; 18:571–89.

2.      Greenspan J. S, Daniels T. E, Talal Nand Sylvester R. A: The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral surgery, oral medicine, and oral pathology. 1974;37(2), 217-29.

3.      Bossini N, Savoldi  S, Franceschini  F, Mombelloni S, Baronio M andCavazzana I: Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. Nephrology, dialysis, and transplantation J. 2001; 16(12), 2328-336.

4.      Lafitte C, Amoura  Z, Cacoub P, Pradat-Diehl P, Picq C andSalachas F: Neurological complications of primary Sjogren's syndrome. Journal of neurology.2001; 248(7), 577-84.

5.      Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV and Hogan MC:Renal involvement in primary Sjögren's syndrome: a clinicopathologic study.Clin J Am SocNephrol. 2009 Sep;4(9):1423-31.

6.      Zandbelt MM, van den Hoogen FH, de Wilde PC, van den Berg PJ, Schneider HG and van de Putte LB: Reversibility of histological andimmunohistological abnormalities in sublabial salivary gland biopsyspecimens following treatment with corticosteroids in Sjogren’s syndrome.Ann Rheum Dis.2001;60:511–13.

7.      Sonia Cristina de Magalhães Souza Fialho, Samuel Bergamaschi, Fabrício Souza Neves, Adriana Fontes Zimmermann, Gláucio Ricardo Werner de Castroand IvânioAlves Pereira:Mycophenolatemofetil in primary Sjogren’ssyndrome: a treatment option for agranulocytosis. Rev Bras Reumatol.2012;52(2):295-99.

8.      Dean C. Preddie, Glen S. Markowitz, Jai Radhakrishnan, Thomas L. Nickolas, Vivette D. D’Agati, Joshua A. Schwimmer, Mark Gardenswartz, Raquel Rosen and Gerald B. Appel: MycophenolateMofetil for the Treatment of Interstitial Nephritis. Clin J Am SocNephrol. 2006; 718–22. 

Walaa H. Mohamad

Nephrology Unit, Assiut University, +201005220944

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.